Risk Factors and Prognosis of Early Neurological Deterioration after Bridging Therapy.

It was found that the incidence of END after BT in AIS patients was 33.67%. An increase in SBP, higher glucose levels at admission, and LAA were independent risk factors of END that predicted a poor prognosis.